These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36438032)

  • 21. Electrochemical investigations for COVID-19 detection-A comparison with other viral detection methods.
    Bukkitgar SD; Shetti NP; Aminabhavi TM
    Chem Eng J; 2021 Sep; 420():127575. PubMed ID: 33162783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development.
    Huang SW; Tai CH; Hsu YM; Cheng D; Hung SJ; Chai KM; Wang YF; Wang JR
    Biomed J; 2020 Aug; 43(4):375-387. PubMed ID: 32611537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live attenuated herpes zoster vaccine for HIV-infected adults.
    Shafran SD
    HIV Med; 2016 Apr; 17(4):305-10. PubMed ID: 26315285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
    Li Q; Zhao Z; Zhou D; Chen Y; Hong W; Cao L; Yang J; Zhang Y; Shi W; Cao Z; Wu Y; Yan H; Li W
    Peptides; 2011 Jul; 32(7):1518-25. PubMed ID: 21620914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.
    Bommireddy R; Stone S; Bhatnagar N; Kumari P; Munoz LE; Oh J; Kim KH; Berry JTL; Jacobsen KM; Jaafar L; Naing SH; Blackerby AN; Gaag TV; Wright CN; Lai L; Pack CD; Ramachandiran S; Suthar MS; Kang SM; Kumar M; Reddy SJC; Selvaraj P
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why are vaccines against many human viral diseases still unavailable; an historic perspective?
    Tannock GA; Kim H; Xue L
    J Med Virol; 2020 Feb; 92(2):129-138. PubMed ID: 31502669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.
    Marshall GS; Senders SD; Shepard J; Twiggs JD; Gardner J; Hille D; Hartzel J; Valenzuela R; Stek JE; Helmond FA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2188-2196. PubMed ID: 27149048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events after vaccination among HIV-positive persons, 1990-2016.
    Su JR; Ng C; Lewis PW; Cano MV
    PLoS One; 2018; 13(6):e0199229. PubMed ID: 29920551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant administration of a bivalent Haemophilus influenzae type b-hepatitis B vaccine, measles-mumps-rubella vaccine and varicella vaccine: safety, tolerability and immunogenicity.
    Hesley TM; Reisinger KS; Sullivan BJ; Jensen EH; Stasiorowski S; Meechan C; Chan CY; West DJ;
    Pediatr Infect Dis J; 2004 Mar; 23(3):240-5. PubMed ID: 15014300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
    Gershon AA; Gershon MD; Shapiro ED
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S387-S397. PubMed ID: 34590140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serosurveillance of varicella and hepatitis B infection after reported cases in medical students and the relationship between past varicella disease history and immunity status.
    Suwanpakdee D; Laohapand C; Moolasart V; Lomtong P; Krairojananan N; Srisawat P; Watanaveeradej V
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S80-5. PubMed ID: 22934450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview and horizons in prevention of some human infectious diseases by vaccination.
    Sabin AB
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):114-27. PubMed ID: 210652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
    Sun W; Leist SR; McCroskery S; Liu Y; Slamanig S; Oliva J; Amanat F; Schäfer A; Dinnon KH; García-Sastre A; Krammer F; Baric RS; Palese P
    bioRxiv; 2020 Jul; ():. PubMed ID: 32743571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccination against acute respiratory virus infections and measles in man.
    Osterhaus AD; de Vries P
    Immunobiology; 1992 Feb; 184(2-3):180-92. PubMed ID: 1587542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine.
    de Martino Mota A; Carvalho-Costa FA
    J Pediatr (Rio J); 2016; 92(4):361-6. PubMed ID: 26969400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic.
    Takashita E; Kawakami C; Momoki T; Saikusa M; Shimizu K; Ozawa H; Kumazaki M; Usuku S; Tanaka N; Okubo I; Morita H; Nagata S; Watanabe S; Hasegawa H; Kawaoka Y
    Influenza Other Respir Viruses; 2021 Jul; 15(4):488-494. PubMed ID: 33715290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
    Freer G; Pistello M
    New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.